Global veterinary dermatology drugs market is anticipated to grow at a CAGR of 9.2% during the forecast period (2024-2031). The focus of governments and regulatory bodies on animal health and welfare has allowed for investments in the dermatology drugs-based veterinary sector with an emphasis on skin diseases and health problems in animals thereby expanding the growth prospects of the global veterinary dermatology drugs market. Furthermore, the awareness for dermatological care for animals is rising, leading to an increase in the need for efficient treatment methods.
To learn more about this report request a sample copy @ https://www.omrglobal.com/request-sample/veterinary-dermatology-drugs-market
For instance, in May 2022, several Indian states experienced a widespread outbreak of Lumpy Skin Disease (LSD) among livestock. LSD is classified as an epizootic rather than a zoonotic illness, caused by the Capripox virus, which shares genetic similarities with the viruses responsible for goat and sheep pox. By October 21st, 2022, approximately 2.4 million animals had been affected by the outbreak, resulting in over 110,000 fatalities.
Additionally, the various strategic decisions of the market players are contributing significantly towards the market growth. For instance, in September 2022, as an illustration, Zoetis finalized the acquisition of Jurox, thereby granting Zoetis access to a significant range of products poised for expanded global reach and bolstering its animal health portfolio with valuable additions.
Global Veterinary Dermatology Drugs Market Report Segment
By Type
- Antifungal Drugs
- Antibacterial Drugs
- Antiparasitic Drugs
By Animal Type
- Companion Animals
- Livestock Animals
By Route of Administration
- Topical
- Oral
- Injectable
By Distribution Channel
- Hospital Pharmacies
- Retail
- E-commerce
By Indication
- Parasitic Infections
- Allergic Infections
- Others (Skin Cancer)
A full report of Veterinary Dermatology Drugs Market available @ https://www.omrglobal.com/industry-reports/veterinary-dermatology-drugs-market
Veterinary Dermatology Drugs Market Report Segment by Region
North America
- United States
- Canada
Europe
- Germany
- United Kingdom
- France
- Spain
- Italy
- Rest of Europe
Asia-Pacific
- China
- Japan
- India
- Rest of Asia-Pacific
Rest of the World
- Middle East & Africa
- Latin America
Company Profiles
- AB Science
- Bayer AG
- Bimeda Holdings Ltd.
- Bioiberica S.A.U.
- Boehringer Ingelheim International GmbH
- IDEXX Laboratories Inc.
- Indian Immunologicals Ltd.
- Leti Pharma, S.L.U.
- Mars, Inc.
- Novartis AG
Reasons to Buying From us –
- We cover more than 15 major industries, further segmented into more than 90 sectors.
- More than 120 countries are for analysis.
- Over 100+ paid data sources mined for investigation.
- Our expert research analysts answer all your questions before and after purchasing your report.
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services. The company also offers Digital Marketing services through its subsidiary OMR Digital and Software development and Consulting Services through another subsidiary Encanto Technologies.
Media Contact:
Contact Person: Mr. Anurag Tiwari
Email: anurag@omrglobal.com
Contact no: +91 780-304-0404
Company Name: Orion Market Research
Visit more report at
https://www.linkedin.com/pulse/scaffold-technology-market-size-trends-latest-arti-vishwakarma-mlsof/
